344950-75-0Relevant academic research and scientific papers
Synthesis and structure-activity relationships of azamacrocyclic C-X-C chemokine receptor 4 antagonists: Analogues containing a single azamacrocyclic ring are potent inhibitors of T-cell tropic (X4) HIV-1 replication
Bridger, Gary J.,Skerlj, Renato T.,Hernandez-Abad, Pedro E.,Bogucki, David E.,Wang, Zhongren,Zhou, Yuanxi,Nan, Susan,Boehringer, Eva M.,Wilson, Trevor,Crawford, Jason,Metz, Markus,Hatse, Sigrid,Princen, Katrien,De Clercq, Erik,Schols, Dominique
supporting information; experimental part, p. 1250 - 1260 (2010/08/07)
Bis-tetraazamacrocycles such as the bicyclam AMD3100 (1) are a class of potent and selective anti-HIV-1 agents that inhibit virus replication by binding to the chemokine receptor CXCR4, the coreceptor for entry of X4 viruses. By sequential replacement and/or deletion of the amino groups within the azamacrocyclic ring systems, we have determined the minimum structural features required for potent antiviral activity in this class of compounds. All eight amino groups are not required for activity, the critical amino groups on a per ring basis are nonidentical, and the overall charge at physiological pHcan be reduced without compromising potency. This approach led to the identification of several single ring azamacrocyclic analogues such as AMD3465 (3d), 36, and 40, which exhibit EC50's against the cytopathic effects of HIV-1 of 9.0, 1.0, and 4.0 nM, respectively, antiviral potencies that are comparable to 1 (EC50 against HIV-1 of 4.0 nM). More importantly, however, the key structural elements of 1 required for antiviral activitymay facilitate the design of nonmacrocyclic CXCR4 antagonists suitable for HIV treatment via oral administration. 2009 American Chemical Society.
